190 related articles for article (PubMed ID: 18926403)
1. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates.
Goland S; Czer LS; Coleman B; De Robertis MA; Mirocha J; Zivari K; Schwarz ER; Kass RM; Trento A
J Heart Lung Transplant; 2008 Oct; 27(10):1115-21. PubMed ID: 18926403
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients.
Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I
Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903
[TBL] [Abstract][Full Text] [Related]
3. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
4. Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation.
De Santo LS; Della Corte A; Romano G; Amarelli C; Onorati F; Torella M; De Feo M; Marra C; Maiello C; Giannolo B; Casillo R; Ragone E; Grimaldi M; Utili R; Cotrufo M
Transplant Proc; 2004 Apr; 36(3):631-7. PubMed ID: 15110616
[TBL] [Abstract][Full Text] [Related]
5. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
De Santo LS; Romano G; Mastroianni C; Roberta C; Della Corte A; Amarelli C; Maiello C; Giannolo B; Marra C; Ragone E; Grimaldi M; Utili R; Scardone M; Cotrufo M
Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
[TBL] [Abstract][Full Text] [Related]
6. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
7. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.
Di Filippo S; Boissonnat P; Sassolas F; Robin J; Ninet J; Champsaur G; Bozio A
Transplantation; 2003 Feb; 75(3):354-8. PubMed ID: 12589158
[TBL] [Abstract][Full Text] [Related]
8. The duration of administration of monoclonal antibody OKT3 for induction immunosuppression after heart transplantation.
Aleksic I; Freimark D; Blanche C; Czer LS; Dalichau H; Valenza M; Takkenberg JJ; Trento A
Thorac Cardiovasc Surg; 1997 Aug; 45(4):190-5. PubMed ID: 9323821
[TBL] [Abstract][Full Text] [Related]
9. Renal retransplantation: a retrospective monocentric study.
Ott U; Busch M; Steiner T; Schubert J; Wolf G
Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
11. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
12. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
Burton CM; Andersen CB; Jensen AS; Iversen M; Milman N; Boesgaard S; Arendrup H; Eliasen K; Carlsen J
J Heart Lung Transplant; 2006 Jun; 25(6):638-47. PubMed ID: 16730569
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.
Mullen JC; Oreopoulos A; Lien DC; Bentley MJ; Modry DL; Stewart K; Winton TL; Jackson K; Doucette K; Preiksaitis J; Halloran PF
J Heart Lung Transplant; 2007 May; 26(5):504-10. PubMed ID: 17449421
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
[TBL] [Abstract][Full Text] [Related]
15. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
[TBL] [Abstract][Full Text] [Related]
16. Influence of induction therapy on rejection and survival in heart transplantation.
Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
[TBL] [Abstract][Full Text] [Related]
17. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
Lischke R; Simonek J; Davidová R; Schützner J; Stolz AJ; Vojácek J; Burkert J; Pafko P
Transplant Proc; 2007; 39(1):205-12. PubMed ID: 17275507
[TBL] [Abstract][Full Text] [Related]
18. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation.
Soliman T; Hetz H; Burghuber C; Györi G; Silberhumer G; Steininger R; Mühlbacher F; Berlakovich GA
Liver Transpl; 2007 Jul; 13(7):1039-44. PubMed ID: 17600336
[TBL] [Abstract][Full Text] [Related]
19. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
20. Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies.
Castro MC; Araujo LM; Nahas WC; Arap S; David-Neto E; Ianhez LE
Transplant Proc; 2004 May; 36(4):874-6. PubMed ID: 15194299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
